# FDA Inspection 1217654 - Eagle Labs, Inc. - August 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/eagle-labs-inc/a6843925-a18e-4c7d-af76-8682edc193b4
Source feed: FDA_Inspections

> FDA Inspection 1217654 for Eagle Labs, Inc. on August 24, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217654
- Company Name: Eagle Labs, Inc.
- Inspection Date: 2023-08-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1294414 - 2026-01-13](https://www.keypedia.com/records/fda_inspections/eagle-labs-inc/ea3333cc-bf01-4688-9fe0-411f72a67867)
- [FDA Inspection 1294414 - 2026-01-13](https://www.keypedia.com/records/fda_inspections/eagle-labs-inc/a6dda9d1-9e99-490c-82d7-940e5b205897)
- [FDA Inspection 1294414 - 2026-01-13](https://www.keypedia.com/records/fda_inspections/eagle-labs-inc/2e61c83c-1433-41e9-bfd4-c260903ad3e6)

Company: https://www.keypedia.com/companies/eagle-labs-inc/b2122424-0d68-4c2d-8212-b726bf0f2dbc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c